pharma

Bolt founder Ryan Breslow isn’t going away

Ryan Breslow has had a tumultuous 2022. It’s not slowing him down. Few outside of Breslow’s world even knew his name a year ago. Then Bolt, a “one-click” checkout tech company that evo

Manifold Bio’s molecular ‘barcodes’ could break through pharma’s in vivo bottleneck

In the creation of a new drug, there comes a point where you have to finally put the molecule in a real creature — one at a time — and see if it actually does what you think it does. Manifold Bio&

SwipeRx lands $27M from MDI and Gates Foundation to digitize the pharma industry in Southeast Asia

SwipeRx, a platform for pharma professionals, said Tuesday it has secured a $27 million Series B round led by Indonesia’s MDI Ventures, with participation from the Gates Foundation, Johnson & Jo

Quris combines AI with ‘patient on a chip’ to speed drug development and reduce animal testing

The necessity of animal testing is a sad one for the process of drug discovery, but there’s seemingly no good alternative to mice, even though they’re not particularly accurate human analo

NFX-backed Pepper Bio Emerges from stealth with tools to hone in on complex diseases

There’s a clear pain point when it comes to drug discovery: Depending on which study you cite, creating an approved drug costs anywhere from $985 million to $2.6 billion. And R&D returns have re

Cell and gene therapy startup ElevateBio raises $170M

While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing round closures with significant mone

Pharma’s Huge Threat (and Opportunity): mRx

It was only a matter of time before healthcare providers would start prescribing mHealth apps as soon as they proved to be as or more effective than prescription drugs. Happtique, a mobile health appl

Index Launches Its First Life Sciences Fund: $200M And Partnering With Glaxo and Johnson & Johnson

Index Ventures may be best known on these pages for its technology investments, but today it launched a new fund that points to how the company is willing to put its money into other examples of stron

Dumb Employers, Lucky Startups And An Untapped Reservoir

A group of women is re-entering the workforce today and reshaping how products are made across key tech sectors like health & wellness, commerce and social products. Not only do they have the expe